ORGANIC
LETTERS
2008
Vol. 10, No. 12
2525-2528
Synthesis of the C1-C23 Fragment of
Spirastrellolide A
Jin-Haek Yang, Jia Liu, and Richard P. Hsung*
DiVision of Pharmaceutical Sciences and Department of Chemistry, 777 Highland
AVenue, UniVersity of Wisconsin, Madison, Wisconsin 53705-2222
Received April 8, 2008
ABSTRACT
Synthesis of the C1-C23 fragment in spirastrellolide A is described, featuring a cyclic acetal-tethered RCM for stereoselective constructions
of spiroketal, and a 1,3-anti aldol involving methyl ketone enolate and Mukaiyama conditions.
The isolation of (+)-spirastrellolide A, a novel spiroketal-
rich macrolide from marine sponge Spirastrellolide coccinea,
was reported by Roberge and Andersen et al.1 In addition
to its ability to initiate premature entry into mitosis and
untimely mitotic arrest in cells, spirastrellolide A exhibits a
potent inhibitory activity against protein phosphatase 2A
[IC50 ) 1 nM] with an excellent selectivity for PP2A over
PP1 [ratio of IC50 values ) 1:50],1,2 and it does not inhibit
PP2C. Its biological activities, therefore, resemble other
known Ser/Thr phosphatase inhibitors fostriecin and okadaic
acid. Development of protein phosphatase inhibitors has
lagged behind interest in kinase inhibitors because of the
perceived notion that kinases are more highly regulated and
specific.3 However, there has been a renewed interest in
recent years because reversible protein phosphorylation is
critical “as the other half” of checkpoints in cell cycles, and
protein phosphatases assume an equally important role in
regulating cellular signal transductions and should not be
ignored. Designing phosphatase inhibitors can lead to new
paradigms in developing cancer therapeutics.3
As a result, this natural product has attracted an elegant
array of synthetic efforts,4 and most recently, the first total
synthesis by Paterson.5 We became interested in spiras-
trellolide A when we developed a cyclic acetal tethered RCM
as an unconventional approach to the synthesis of spiroket-
als.6,7 Consequently, we pursued the synthesis of an epimer
[at C22] of the C11-23 fragment to showcase our method.8
(3) (a) For a leading review, see: Oliver, C. J.; Shenolikar, S. Front.
Biosci. 1998, 3, 961. Also see: (b) Paterson, I.; Anderson, E. A. Science
2005, 310, 451. (c) Koehn, F. E.; Carter, G. T. Nat. ReV. Drug DiscoVery
2005, 4, 206. (d) Paterson, I.; Yeung, K.-S. Chem. ReV. 2005, 105, 4237.
(e) Newmann, D. J.; Cragg, G. M. J. Nat. Prod. 2007, 70, 461.
(4) For elegant synthetic efforts toward spirastrellolide A, see: (a)
Paterson, I.; Anderson, E. A.; Dalby, S. M.; Loiseleur, O. Org. Lett. 2005,
7, 4121. (b) Paterson, I.; Anderson, E. A.; Dalby, S. M.; Loiseleur, O. Org.
Lett. 2005, 7, 4125. (c) Paterson, I.; Anderson, E. A.; Dalby, S. M.; Lim,
J. H.; Maltas, P.; Moessner, C. Chem. Commun. 2006, 4186. (d) Paterson,
I.; Anderson, E. A.; Dalby, S. M. Synthesis 2005, 3225. (e) Fu¨rstner, A.;
Fenster, M. D. B.; Fasching, B.; Godbout, C.; Radkowski, K. Angew. Chem.,
Int. Ed. 2006, 45, 5506. (f) Fu¨rstner, A.; Fenster, M. D. B.; Fasching, B.;
Godbout, C.; Radkowski, K. Angew. Chem., Int. Ed. 2006, 45, 5510. (g)
Pan, Y.; De Brabander, J. K. Synlett 2006, 853. (h) Wang, C.; Forsyth,
C. J. Org. Lett. 2006, 8, 2997. (i) Paterson, I.; Anderson, E. A.; Dalby,
S. M.; Lim, J. H.; Loiseleur, O.; Maltas, P.; Moessner, C. Pure Appl. Chem.
2007, 79, 667. (j) Smith, A. B., III; Kim, D.-S. Org. Lett. 2007, 9, 3311.
(k) Keaton, K. A.; Phillip, A. J. Org. Lett. 2008, 10, 1083.
(1) For isolations of spirastrellolide A, see: (a) Williams, D. E.; Roberge,
M.; Van Soest, R.; Andersen, R. J. J. Am. Chem. Soc. 2003, 125, 5296. (b)
Williams, D. E.; Lapawa, M.; Feng, X.; Tarling, T.; Roberge, M.; Andersen,
R. J. Org. Lett. 2004, 6, 2607. For isolations of spirastrellolide B, see: (c)
Warabi, K.; Williams, D. E.; Patrick, B. O.; Roberge, M.; Andersen, R. J.
J. Am. Chem. Soc. 2007, 129, 508. For C-G, see: (d) Williams, D. E.;
Keyzers, R. A.; Warabi, K.; Desjardine, K.; Riffell, J. L.; Roberge, M.;
Andersen, R. J. J. Org. Chem. 2007, 72, 9842.
(2) Roberge, M.; Cinel, B.; Anderson, H. J.; Lim, L.; Jiang, X.; Xu, L.;
Bigg, C. M.; Kelly, M. T.; Andersen, R. J. Cancer Res. 2000, 60, 5052
.
10.1021/ol8008057 CCC: $40.75
Published on Web 05/17/2008
2008 American Chemical Society